Cygnal Therapeutics

0 followers


Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology.

Industries

Employees

11-50

Links

Org chart

Pearl Huang
President & CEO

Pearl Huang

Collapse
John Wagner
Chief Medical Officer
Ljiljana Minwalla
SVP, Business Development & Legal Affairs
Timothy Zheng
SVP, Biology

Board & advisors

Noubar Afeyan
Founding Chairman
Theo Melas-Kyriazi
Chairman, Board of Directors
Doug Cole
Director
Michelle Monje
Scientific Advisor
Erica Sloan
Scientific Advisor
Timothy Cragin Wang
Scientific Advisor
Robert Weinberg
Scientific Advisor
Ulrich von Andrian
Scientific Advisor
John Furness
Scientific Advisor
Clifford Woolf
Scientific Advisor
Hubert Hondermarck
Scientific Advisor
David Tuveson
Scientific Advisor
Jennifer Petter
Scientific Advisor